Karyopharm Therapeutics Inc stock is traded at $0.0729, with a volume of 40,915,199. It is down -17.44% in the last 24 hours and down -89.13% over the past month. Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Previous Close:
$0.0883
Open:
$0.081
24h Volume:
40,915,199
Relative Volume:
2.24
Market Cap:
$1.65M
Revenue:
$151.12M
Net Income/Loss:
-$194.97M
P/E Ratio:
-
EPS:
-$15.09
Net Cash Flow:
-$59.11M
1W Performance:
-91.71%
1M Performance:
-89.13%
6M Performance:
-99.23%
1Y Performance:
-98.64%
1-Day Range:
$0.00$0.00
1-Week Range:
$0.0729$0.902
52-Week Range:
$0.0729$10.99
Karyopharm Therapeutics Inc Stock (KPTI) Company Profile
Name
Karyopharm Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
617-658-0600Address
85 WELLS AVENUE, NEWTON, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS